Table 2 Comorbidities of the study participants.
DC N = 262 | PD N = 590 | p-value | p-value* | |
|---|---|---|---|---|
Neurological conditions | ||||
Vertigo/dizziness | 1 (0.4%) | 55 (9.3%) | <0.001 | 0.001 |
Essential tremor | 1 (0.4%) | 31 (5.2%) | <0.001 | 0.010 |
Restless legs syndrome | 4 (1.5%) | 38 (6.4%) | 0.002 | 0.004 |
Epilepsy | 3 (1.1%) | 8 (1.2%) | 0.811 | 0.670 |
Migraine | 5 (1.9%) | 18 (3%) | 0.351 | 0.210 |
Stroke | 20 (7.6%) | 44 (7.5%) | 0.903 | 0.820 |
Polyneuropathy | 7 (2.7%) | 31 (5.2%) | 0.096 | 0.110 |
Non-neurological conditions | ||||
Joint diseases | 25 (9.5%) | 105 (17.8%) | 0.002 | 0.002 |
Back pain | 14 (5.3%) | 103 (17.3%) | <0.001 | <0.001 |
Arterial hypertension | 46 (17.5%) | 202 (34%) | <0.001 | 0.990 |
Thyroid disease | 13 (5%) | 85 (14.4%) | <0.001 | <0.001 |
Hyperlipidemia | 9 (3.4%) | 49 (8.3%) | 0.010 | 0.014 |
Cardiac arrhythmias | 6 (2.3%) | 49 (8.3%) | 0.001 | 0.007 |
Cancer | 0 (0%) | 45 (7.6%) | <0.001 | 0.994 |
Coronary heart disease | 25 (9.5 %) | 62 (10.5%) | 0.695 | 0.898 |
Diabetes mellitus | 23 (8.8%) | 65 (11%) | 0.340 | 0.512 |
